Soldini, Aldo http://orcid.org/0009-0000-5460-0747
Vogelmann, Ulrike
Aust, Sabine
Goerigk, Stephan
Plewnia, Christian
Fallgatter, Andreas
Normann, Claus
Frase, Lukas
Zwanzger, Peter
Kammer, Thomas
Schönfeldt-Lecuona, Carlos
Vural, Gizem
Bajbouj, Malek
Padberg, Frank
Burkhardt, Gerrit
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01EE1403G)
Universitätsklinik München
Article History
Received: 28 July 2023
Accepted: 13 January 2024
First Online: 26 February 2024
Declarations
:
: FP has received consulting fees from Brainsway Inc. (Jerusalem, Israel) as a member of the European Scientific. Advisory Board and from Sooma (Helsinki, Finland) as a member of the International Scientific. Advisory Board; honoraria for workshops from Mag&More GmbH (Munich, Germany); and honoraria for lectures from neuroCare Group (Munich, Germany) and Brainsway Inc. (Jerusalem, Israel); and has received equipment from Mag&More GmbH (Munich, Germany), neuroCare Group (Munich, Germany), and Brainsway Inc. (Jerusalem, Israel). BL received honoraria for consultancy and speakers’ fees from ANM, AstraZeneca, Autifony Therapeutics, Decibel Therapeutics, Desyncra, Gerson Lehmanns Group, Lundbeck, Merz, MagVenture, Medical Tribune, Neurolite, Neuromod, Novartis, Pfizer, Rovi, Schwabe, Sea Pharma, Servier, Sonova and Sound Therapeutics; research funding from the Tinnitus Research Initiative, Bayhost, the German Research Foundation, the German Federal Ministry of Education and Research, the American Tinnitus Association, AstraZeneca, cerbomed, Neuromod and the European Union; and has received equipment from MagVenture and Deymed Diagnostic. CP is managing partner of PsyKit GmbH, Tübingen, Germany. AS, UV, GV, LF, AJF, GB, CSL, SG, SA, CP, CN, LF, PZ, TK, and MB declare no competing interests.